Spotlight on AbbVie: Analyzing the Surge in Options Activity
Spotlight on AbbVie: Analyzing the Surge in Options Activity
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for AbbVie's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AbbVie's whale trades within a strike price range from $165.0 to $195.0 in the last 30 days. Financial giants have made a conspicuous bullish move on AbbVie. Our analysis of options history for AbbVie (NYSE:ABBV) revealed 8 unusual trades.
金融巨头对艾伯维公司采取了明显的看好举动。我们对艾伯维公司（NYSE:ABBV）期权历史进行分析，发现了8笔异常交易。
Delving into the details, we found 37% of traders were bullish, while 12% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $325,314, and 4 were calls, valued at $527,350.
深入细节，我们发现37%的交易者持看好态度，而12%显示出看跌倾向。在我们发现的所有交易中，有4笔为看跌期权，价值 $325,314，以及4笔为看涨期权，价值 $527,350。
Projected Price Targets
预计价格目标
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $165.0 to $195.0 for AbbVie during the past quarter.
分析这些合约的成交量和未平仓合约量，似乎大型交易者一直关注艾伯维公司在过去一个季度内的价格区间从$165.0到$195.0。
Volume & Open Interest Trends
成交量和未平仓量趋势
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for AbbVie's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AbbVie's whale trades within a strike price range from $165.0 to $195.0 in the last 30 days.
在交易期权时，查看成交量和未平仓合约量是一个强大的举措。这些数据可以帮助您跟踪给定行权价格下艾伯维公司期权的流动性和兴趣。下面，我们可以观察过去30天内所有艾伯维公司大额交易的看涨和看跌期权的成交量和未平仓合约量的演变，分别在$165.0到$195.0的行权价格范围内。
AbbVie Option Volume And Open Interest Over Last 30 Days
艾伯维期权成交量和未平仓利息过去30天的变化
Largest Options Trades Observed:
观察到的最大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | CALL | SWEEP | BEARISH | 09/20/24 | $28.4 | $27.15 | $28.0 | $165.00 | $361.2K | 1.4K | 29 |
| ABBV | PUT | TRADE | BULLISH | 12/20/24 | $3.8 | $3.7 | $3.71 | $180.00 | $204.0K | 8 | 553 |
| ABBV | CALL | TRADE | BULLISH | 12/20/24 | $8.1 | $8.05 | $8.1 | $195.00 | $101.2K | 363 | 125 |
| ABBV | PUT | TRADE | NEUTRAL | 09/20/24 | $2.12 | $1.83 | $1.95 | $195.00 | $58.5K | 3.3K | 1.0K |
| ABBV | PUT | TRADE | NEUTRAL | 01/16/26 | $18.25 | $17.75 | $17.98 | $190.00 | $35.9K | 646 | 20 |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 艾伯维公司 | 看涨 | SWEEP | 看淡 | 09/20/24 | $28.4 | $27.15 | $28.0 | 165.00美元 | $361.2千美元 | 1.4千 | 29 |
| 艾伯维公司 | 看跌 | 交易 | 看好 | 12/20/24 | $3.8 | $3.7 | $3.71 | 180.00美元 | $204,000 | 8 | 553 |
| 艾伯维公司 | 看涨 | 交易 | 看好 | 12/20/24 | $8.1 | $8.05 | $8.1 | $195.00 | $101.2千 | 363 | 125 |
| 艾伯维公司 | 看跌 | 交易 | 中立 | 09/20/24 | $2.12 | $1.83 | $1.95 | $195.00 | $58.5K | 3.3K | 1.0K |
| 艾伯维公司 | 看跌 | 交易 | 中立 | 01/16/26 | $18.25 | $17.75 | $17.98 | $190.00 | $35.9K | 646 | 20 |
About AbbVie
关于艾伯维公司
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
AbbVie是一家药品公司，其在免疫学（包括Humira、Skyrizi和Rinvoq）和肿瘤学（包括Imbruvica和Venclexta）方面拥有强大的业务。该公司于2013年初从Abbott分拆而来。2020年收购雅培使其在美容业务（包括Botox）中新增了一些产品和药品。
Following our analysis of the options activities associated with AbbVie, we pivot to a closer look at the company's own performance.
在对艾伯维公司相关期权活动进行分析后，我们转而更近距离地查看该公司的表现。
Current Position of AbbVie
艾伯维公司的当前头寸
- With a trading volume of 3,370,211, the price of ABBV is down by -0.39%, reaching $192.86.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 35 days from now.
- ABBV的交易量为3,370,211，价格下跌-0.39%，达到192.86美元。
- 目前的RSI值表明该股票目前处于超买和超卖之间的中立状态。
- 下一份财报将于35天后公布。
Expert Opinions on AbbVie
关于艾伯维公司的专家意见
In the last month, 1 experts released ratings on this stock with an average target price of $209.0.
在过去一个月里，1位专家发布了对该股票的评级，平均目标价为209.0美元。
Turn $1000 into $1270 in just 20 days?
在短短20天内，将1000美元变成1270美元？
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.* Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on AbbVie with a target price of $209.
20年期权交易专家揭示了他的一行图表技术，显示何时买入和卖出。复制他的交易，平均每20天盈利27%。点击这里获取.* 派杰投资的分析师保持对艾伯维公司的股票评级为超配，目标价为209美元。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for AbbVie with Benzinga Pro for real-time alerts.
交易期权涉及更高风险，但同时也提供实现更高利润的潜力。精明的交易者通过持续教育、战略性交易调整、利用各种因子以及保持对市场动态的关注来减轻这些风险。使用Benzinga Pro跟踪AbbVie的最新期权交易以获取实时警报。
